| scholarly article | Q13442814 |
| P50 | author | Vladimer Darsalia | Q55127431 |
| Cesare Patrone | Q59689710 | ||
| Grazyna Lietzau | Q59707028 | ||
| P2093 | author name string | Thomas Nyström | |
| Claes-Göran Östenson | |||
| P2860 | cites work | Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model | Q24603560 |
| Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke | Q26861493 | ||
| Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease | Q27021770 | ||
| Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide | Q28081671 | ||
| The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes | Q28273497 | ||
| Global estimates of the prevalence of diabetes for 2010 and 2030 | Q29547218 | ||
| Hyperlipidemic diet causes loss of olfactory sensory neurons, reduces olfactory discrimination, and disrupts odor-reversal learning | Q30409547 | ||
| Evaluation of olfactory dysfunction in neurodegenerative diseases | Q30570590 | ||
| GLP-1 for type 2 diabetes | Q33794098 | ||
| Crucial role of calbindin-D28k in the pathogenesis of Alzheimer's disease mouse model | Q34153507 | ||
| Olfaction under metabolic influences. | Q34290268 | ||
| Prevalence of olfactory dysfunction: the Skövde population-based study | Q34546869 | ||
| Calcium dysregulation in the aging brain | Q34795483 | ||
| Preproglucagon neurons project widely to autonomic control areas in the mouse brain. | Q34981134 | ||
| Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats | Q35709472 | ||
| Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice | Q35929005 | ||
| Olfaction in Parkinson's disease and related disorders | Q36193915 | ||
| Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies | Q36311526 | ||
| Risk of dementia in diabetes mellitus: a systematic review | Q36345254 | ||
| Islet gene expression and function in type 2 diabetes; studies in the Goto-Kakizaki rat and humans | Q36962198 | ||
| Central mechanisms of odour object perception | Q37044173 | ||
| Odor representations in olfactory cortex: "sparse" coding, global inhibition, and oscillations | Q37242939 | ||
| Incretin-based therapies for type 2 diabetes mellitus | Q37483473 | ||
| Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease. | Q37718840 | ||
| Neurons and circuits for odor processing in the piriform cortex | Q38104518 | ||
| The role of type 2 diabetes in neurodegeneration | Q38450518 | ||
| Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress | Q39083326 | ||
| The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. | Q39540612 | ||
| A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells | Q40748616 | ||
| Production of spontaneous diabetic rats by repetition of selective breeding | Q41059786 | ||
| Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways | Q42165735 | ||
| Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer's disease. | Q42457698 | ||
| Diverse Patterns of Odor Representation by Neurons in the Anterior Piriform Cortex of Awake Mice | Q42781236 | ||
| Presence of Neuropathic Pain May Explain Poor Performances on Olfactory Testing in Diabetes Mellitus Patients | Q43820486 | ||
| Diverse interneuron populations have highly specific interconnectivity in the rat piriform cortex | Q44214836 | ||
| Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy | Q44240871 | ||
| The glucagon-like peptide-1 receptor--or not? | Q44489452 | ||
| Diabetes drugs and neurological disorders: new views and therapeutic possibilities. | Q45334024 | ||
| Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia | Q46132048 | ||
| Early learning and retention of a conditioned taste aversion | Q46352157 | ||
| GLP-1 and exendin-4 transiently enhance GABAA receptor-mediated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons. | Q47831016 | ||
| Diabetic type II Goto-Kakizaki rats show progressively decreasing exploratory activity and learning impairments in fixed and progressive ratios of a lever-press task | Q48217441 | ||
| Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system | Q48306367 | ||
| Phosphotyrosine-Containing Proteins in the CNS of Obese Zucker Rats Are Decreased in the Absence of Changes in the Insulin Receptor | Q48328897 | ||
| Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes | Q48422656 | ||
| Genetically obese Zucker rats have abnormally low brain insulin content | Q48521130 | ||
| Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus | Q50609399 | ||
| Altered conditioned taste aversion and glucose utilization in related brain nuclei of diabetic GK rats | Q52055295 | ||
| Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice | Q52151966 | ||
| Olfaction in patients with mild cognitive impairment and Alzheimer's disease | Q53284084 | ||
| Neurodegenerative disease: Diabetes, microvascular pathology and Alzheimer disease | Q53302227 | ||
| Smell Threshold in Diabetes Mellitus | Q58988254 | ||
| Smell dysfunction and related factors in diabetic patients | Q72815352 | ||
| Entry of exendin-4 into brain is rapid but may be limited at high doses | Q73107463 | ||
| NeuN/Fox-3 is an intrinsic component of the neuronal nuclear matrix | Q84187242 | ||
| Clinical significance of smell and taste disorders in patients with diabetes mellitus | Q84717443 | ||
| Olfactory dysfunction in type 2 diabetes mellitus: an additional manifestation of microvascular disease? | Q87328884 | ||
| Evidence for cortical neuronal loss in male type 2 diabetic Goto-Kakizaki rats | Q87468131 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 5865-5876 | |
| P577 | publication date | 2016-02-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4 | |
| P478 | volume | 7 |
| Q41203188 | Activation of GLP-1 Receptor Enhances Neuronal Base Excision Repair via PI3K-AKT-Induced Expression of Apurinic/Apyrimidinic Endonuclease 1 |
| Q50963300 | Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats |
| Q37473323 | Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4. |
| Q89804406 | Long-Lasting Exendin-4 Fusion Protein Improves Memory Deficits in High-Fat Diet/Streptozotocin-Induced Diabetic Mice |
| Q58557864 | Neonatal exposure to propofol affects interneuron development in the piriform cortex and causes neurobehavioral deficits in adult mice |
| Q92605378 | Sugar in mind: Untangling a sweet and sour relationship beyond type 2 diabetes |
| Q50348623 | Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin |
Search more.